Dr. D'Cruz MS, DNB, FRCS (Hon) is Director Oncology Apollo Cancer Centres. He is a well-recognised as a global leader, clinician, researcher and teacher in Head and Neck Oncology. He was Director of Tata Memorial Hospital and Chief of Head Neck Services with over 33 years experience in the field of cancer. Dr D'Cruz is currently President, Union for International Cancer Control, Headquartered in Geneva. The UICC is the largest cancer organisation globally committed to the cause of cancer control comprising of 1121 member organisations across 171 countries. Established in 1933, he is the first Indian to hold this position. In recognition of his professional standing in the field, he was awarded the Honorary FRCS from the Royal College of Surgeons London.

Dr. D'Cruz has held leadership positions & is on the board of numerous professional organisations, universities, research organisations and cancer institutions across the country and abroad. He is an avid researcher & his landmark contribution in management of neck nodes in oral cancers awarded the plenary at the American society of Clinical Oncology (ASCO) 2015 and subsequently published in the New England journal of Medicine, the first from the Tata Memorial Hospital in this prestigious journal. He worked on research in the use of curcumin and was part of a project to develop and validate molecular cytogenetic studies / Proteomics in oral cancers, results of which were filed for a patent.

Dr. D'Cruz has more than 250 peer-reviewed publications and chapters to his name and is a member of the Editorial Board of many reputed national and international journals.

He has delivered more than 500 invited lectures and nearly a 100 named lectures, key notes and orations both nationally and internationally. He has also been a special invitee to over 100 conferences nationally and internationally to demonstrate head and neck, thyroid surgery. Dr. D'Cruz's special areas on interest are oral \ laryngeal cancers, thyroid, parathyroid, salivary glands and neck diseases. He is also specially trained for head & neck surgery at Sloan Kettering Cancer Centre, New York, Laser Surgery at Vanderbilt University, USA and speech rehabilitation at Indianapolis, Indiana, USA. Thyroid cancer is a area of special interests.

Dr. D'Cruz is a much sought after teacher and was instrumental in initiating the super speciality training course in Head Neck Oncology for the first time in India.

Dr. Tejinder Singh, MD, DM (Medical Oncology), is a Consultant, Medical Oncology at Apollo Hospitals, Navi Mumbai. He has completed Certification course in Essentials of Palliative Care (Basics) and Clinical placement in Palliative Care Certificate from Indian Association of Palliative Care. He has also attended Good Clinical Practices (GCP) trainings both in India and abroad. He holds more than 10 years of experience in the field of Medical Oncology.

Dr. Tejinder Singh has rich experience in the field of Oncology and has been associated with leading hospitals in the country. His passion for teaching made him the Assistant Professor and Head of Dept of Medical Oncology at one of the leading Medical Colleges in Mumbai.

He has been an active contributor in Medical Education & Research and had been the co-investigator for various Clinical Researches.

Dr. Tejinder also has a number of publications and research to his credit.

Dr. (Prof.) Jyoti Bajpai is Lead - Medical & Precision Oncology (Mumbai & Maharashtra region) at Apollo Cancer Centers. She has completed her MBBS & MD in general medicine from N.S.C.B. Medical College, Jabalpur, India. She went on to pursue DM in Medical Oncology from AllMS, New Delhi along with international observerships in Immuno-Oncology & Melanoma, and Bone & Soft Tissue Sarcoma at Memorial Sloan Kettering Cancer Center, New York and Johns Hopkins University School of Medicine, Baltimore respectively.

Experience

• She is a specialist in Precision Medicine & Immunotherapy, renowned for her expertise in Rare Cancers (inclusive of Bone & Soft tissue sarcomas, Skin cancers), Women Cancers (Breast & Gynaecological), Cancer in Advanced & Challenging situations like Pregnancy associated cancers, Adolescents & Young adult cancers, Geriatric cancers and Cancer with co-morbid conditions.
• Her career at Tata Memorial Centre spans from a Lecturer to Professor Medical Oncology and Breast Cancer convener over last 15 years.
• She has been in leadership positions in international societies of high repute like Society of Immunotherapy in Cancers (SITC) as Global Access & Impact Committee core member-USA, Faculty for Immuno-Oncology at European Society of Medical Oncology (ESMO) and immediate past faculty for Sarcomas as well as core committee member for Women for Oncology (W40)-ESMO.
• She is an integral part of several national lead societies and serving as Founding General Secretary for the Immuno-Oncology Society of India (I-OSI), Joint Secretary for Indian Society of Medical & Pediatric Oncology (ISMPO) & Teenage & Young Adult Cancer Foundation (TYAcan) and Chair for W40 India (under ISMPO) and SFO,
• Dr. Bajpai is an avid researcher with 196 publications in lead international & national journals of high impact predominantly as lead author, focusing on rare cancers, women cancers, developing low-cost, efficacious protocols for low-middle income countries, workforce disparity, adolescent and young adult cancers and Immuno-Oncology and Precision Medicine.
• She was involved in various academic and research activities, including international mentorship program under the umbrella of ESMO & ASCO and SFO and curriculum development for HBNI fellowship Immuno-Oncology program, thesis guidance for several students in India, SAARC region and other low middle-income countries.

Areas of interest

• Precision Medicine
• Immuno-Oncology
• Rare cancers (Sarcomas, Skin cancers, LGBTQ+ cancers, pregnancy associated cancer)
• Breast cancer
• Gynecological cancers. Adolescent & young adult cancers Geriatric cancers
• Integrated cancer care inclusive ofenhanced supportive care and palliative medicine

Awards and certifications International

• Global Access & Impact Committee core member - Society of Immunotherapy in Cancers (SITC), USA
• Faculty for Immuno-Oncology at European Society of Medical Oncology (ESMO).
• Immediate past faculty for Sarcomas - ESMO
• Core committee member for Women for Oncology (W40)-ESMO,
• Founder chair for Women for Oncology – SAARC (under SAARC Federation of Oncology (SFO)

National

• Founder General Secretary - Immuno-Oncology Society of India (IOSI)
• Executive member - Indian Society of Medical and Pediatric Oncology (ISMPO)
• Founder chair for Women for Oncology - India (under the banner of ISMPO)
• Founder Member and current Joint Secretary - Teenage and Young Cancer Association (TYAcan)
• Breast disease management group, Tata Memorial Centre – Convenor

Dr. Nita S. Nair is Lead Consultant Breast Surgery, Apollo Cancer Centers, Navi Mumbai. She has completed her MBBS from Grant Medical College, Mumbai, DNB (General Surgery) from P.D. Hinduja National Hospital, Mumbai, MRCS (Edinburgh) from the Royal College of Surgeons Edinburgh and M.Ch (Surgical Oncology) from Tata Memorial Hospital, Mumbai.

Experience

• Senior professor, consultant surgeon and convenor of the breast disease management group at Tata Memorial hospital with over 20 years of clinical experience.
• Executive committee member of the Associations of Breast Surgeons of India and Comprehensive Breast Collaborative Society.
• Landmark research in the management of the breast cancer. Lead co-investigator and author in landmark publications including those on role of surgery in metastatic breast cancer, perioperative role of lidocaine in early breast cancer.
• Delivered more than 200 invited lectures both nationally and internationally, with over 100 peer reviewed publications and chapters.
• Faculty at the University of East Anglia (U.K.) masters of oncoplastic course and has trained numerous students.

Areas of Interests

• Breast Diseases
• Oncoplastic breast surgery
• Young women with breast cancer
• Survivorship and Quality of life issues

Dr. Rajesh S. Shinde MS, M.Ch., is a Consultant HPB, GI & Thoracic Oncology at Apollo Cancer Centres, Navi Mumbai. He has rich experience in performing complex colorectal, stomach, liver, pancreas, gall bladder, bile duct and retroperitoneal tumor surgeries.

Dr. Shinde completed his Surgical Oncology training from Tata Memorial Hospital, Mumbai. He trained in Robotic surgery at Severance Hospital, Yonsei University, Seoul - considered the mother institute for Robotic surgery in the world with maximum number of available robotic systems in a single institute. He also trained in advanced Pancreatic and HPB Surgery at University of Verona, Italy, an apex centre for pancreatic surgeries in Italy.

He has a strong academic record with numerous published Medline/pub Med articles and book chapters. His special areas of interest include complex abdominal organ cancer surgeries with robotic and minimally invasive approaches. In the field of HPB surgery his interests lie in major liver and pancreatic resectional surgery for primary and secondary cancers. In the field of colorectal surgery his interests lie in robotic surgeries and sphincter preservation rectal surgeries.

Dr. Shrikanth Atluri is Consultant Uro Oncology & Robotic Surgery at Apollo Cancer Centres in Navi Mumbai. He has completed his MBBS from Byramjee Jeejeebhoy Medical School and Sassoon Hospital, Pune; MS General Surgery from Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital; MCh in Urology from Bombay Hospital Institute of Medical Sciences; HBNI Uro-Oncology Fellowship at Tata Memorial Hospital, Mumbai, India; Uro-Oncology Fellowship from University of Miami/Jackson Memorial Hospital, Miami and Robotic Urology/Laparoscopic Urology Fellowship from University of Miami/Jackson Memorial Hospital, Miami.

Experience

• Consultant Uro-Oncologist and Robotic Surgeon at prominent hospital in Mumbai.
• He has been sub-editor for a medical journal.
• He has published various scientific papers in national & international journals.
• He haspresented various scientific studies at national & international forums.

Areas of interest

• Robot Assisted Radical Prostatectomy (RARP) for prostate cancer
• Open / Robotic partial or radical nephrectomy for kidney cancer
• Open / Robotic radical cystectomy for bladder cancer
• Surgeries for penile & testicular cancers and adrenal gland
• 2^nd opinion in urology cancers
• Genetic testing for urology cancers

Dr. Vivek Venkatramani is Consultant Uro-Oncologist and Robotic surgeon at AHNM as part of Uro Oncology & Robotic Associates (UORA) with OPD and IPD rights. Dr. Vivek completed MS in General Surgery from Seth G.S. Medical College & KEM hospital in 2009 and MCh (Urology) Gold Medalist from Christian Medical college, Vellore in 2013. He then completed fellowship in Urologic Oncology from University of Miami health systems, Sylvester comprehensive Cancer Center and Jackson Memorial Hospital in 2017.

Experience

• He is a visiting consultant at prominent hospitals in Mumbai and Navi Mumbai.
• He has served as Assistant professor in the department of Urology and Renal Transplantation at CMC Vellore from 2014 to 2015 and Clinical instructor in Urology and Urologic Oncology at Sylvester comprehensive Cancer Center and Jackson Memorial Hospital between 2017 - 2018.
• He has vast exposure to Urology, Uro Oncology and Robotic Surgery procedures and published more than 50 research papers and book chapters in 2 National & 1 International textbooks.
• He has won awards and recognition for his unique scientific papers at national and international conferences.

Areas of interest

• Uro Oncology and Robotic assisted Surgeries
• Prostate Cancer and Benign Prostate Hyperplasia
• Kidney cancer
• Hematuria (blood in urine) and Urinary Bladder Cancer
• Penile lesions and penile cancer
• Scrotal and testicular lumps, testicular cancer
• Adrenal masses

He is an active member of the following organizations

• American Urological Association
• Urological Society of India
• Indian Medical Association
• West Zone - Urological Society of India
• Associate Member, Association of Southern Urologists
• Mumbai Urologic Society

Dr. Ashwin Sunil Tamhankar; MBBS, MS, MCh Urology, DNB Urology, RCS Eng Robotic Fellowship, UK is Consultant Uro-oncologist and Robotic Surgeon at Apollo Cancer Centres, Navi Mumbai.

After completion of his M.Ch Urology from Sion Hospital, Mumbai, he pursued his focussed interest in the field of Uro-oncology for three years. He has gained thorough and dedicated experience in Uro-oncology and Robotic surgeries for one year each at the Tata Memorial Hospital, Mumbai and Max Hospital, New Delhi (Vattikuti Foundation Robotic Uro-oncology Fellowship) and a Robotic Urology Fellowship at the Lister Hospital, United Kingdom with a certification by the Royal College of Surgeons of England and British Association of Urological Surgeons, which is one of the most prestigious achievements in this field across the globe. He has been a part of over 280 robotic procedures in Urology, being the primary surgeon in approximately 90 cases.

Dr. Ashwin Sunil Tamhankar has published extensively in the field of uro-oncology and he holds 48 peer reviewed publications in various international and national journals. He has also presented 30 papers in various national and international urology conferences and written 7 book chapters. He is recognised as an invited faculty by the Urological Society of India (USI). He holds several accolades including Dr. G. M. Phadke travelling fellowship-USI, Dr. Sitharaman memorial prize-USI, Dr. Brij Kihore Patna prize-USI, and USI Got Talent, Shri K. Subramaniam Memorial award, Dr. A. V. Baliga memorial prize and recognition by the University for standing third in the urology examination.

He specialises in the open, laparoscopic (keyhole) and robotic procedures for the cancers in urology involving prostate, kidney, urinary bladder, testis, penis and adrenal. His niche areas of expertise include nerve sparing robotic radical prostatectomy (RARP) for prostate cancer, open radical cystectomy or robot assisted radical cystectomy with total intracorporeal urinary diversion (RARC + IUD) for bladder cancer, open or robot assisted radical nephroureterectomy for the upper tract (ureter) urothelial cancer, robot assisted partial nephrectomy (RAPN) for kidney cancer, laparoscopic or robot assisted radical nephrectomy (RRN) for kidney cancer, robotic or laparoscopic adrenalectomy, surgeries for penile and testicular cancer including retroperitoneal lymph node dissection (RPLND), enhanced recovery after surgery pathway (ERAS) and minimally invasive lymphadenectomy which stands as an inevitable part of any cancer surgery.

In addition to the extirpative cancer surgeries he is a strong believer of preventive oncology and early detection of cancer with the help of various diagnostic pathways like PSA screening, transperineal prostate biopsy and blue light cystoscopy.

Dr. Ashwin Tamhankar does practise exclusive Urooncology (cancers in urology) including the state of the art da Vinci robotic surgeries. He is committed to delivering the best possible care to the cancer patients and to have a robust Urooncology and Robotic program at the Apollo Hospitals, Navi Mumbai.

Dr. Richa Bansal: MBBS, MS (Obs & Gyn), DNB, MCh Gynecological Oncology is a Consultant Gynec Oncosurgeon, Laparoscopic and Robotic Surgeon at Apollo Cancer Centres, Navi Mumbai.

She completed her MBBS from Padmashree Dr. D. Y. Patil Medical college, Nerul, Navi Mumbai and her MS Obstetrics and Gynecology from Lokmanya Tilak Medical College and Hospital which is one of the busiest and most reputed Municipal hospitals in Mumbai.

Dr. Richa Bansal then pursued her MCh Gynecological Oncology from the prestigious Tata Memorial Hospital, Mumbai, where she has worked for over 6 years in the department of Gynecological Oncology. Tata Memorial Hospital is one of largest tertiary referral cancer centres of the world. She also served as an Adhoc Consultant in the Department of Gynecological Oncology at Tata Memorial Hospital.

Dr. Richa Bansal has a focused and high volume practice in the field of Gynecological Oncology for the last 10 years. She is considered to be a Key opinion leader in the field among the medical community. Her surgical expertise is performing all the supra major gynecological oncological procedures including open, laparoscopic (keyhole) and robotic surgeries for Gynecological cancers including cancer of ovary, uterus, cervix, vagina, and vulva. Her niche areas of expertise include cytoreductive surgeries and HIPEC for cancer ovary and peritoneal surface malignancies, open or Robotic radical hysterectomy and retroperitoneal lymph node dissection for cancer of the uterus and cervix, radical vulvectomy and groin lymph node dissection.

Dr. Richa Bansal has a special interest is dealing with gynecological malignancies in young women. Treatment decisions for these young women have to be strategically planned so as to preserve their reproductive and hormonal function without compromising their oncological outcomes. She also has a vast experience in treating women with Familial/Hereditary Cancer syndromes and in offering Genetic counselling and testing.

In addition to performing radical cancer surgeries, prevention of cancer and spreading cancer awareness are also her passion and she has been an invited speaker for Cancer awareness in women on several national and International platforms. She has presented scientific papers in several national and international conferences and has also contributed to book chapters in the field of Gynecological Cancers.

Dr. Richa Bansal is committed to deliver the best care and treatment to the women with gynecological cancers and also to have a dedicated HIPEC and Robotic programme at Apollo hospital, Navi Mumbai.

Dr. Sandeep De, MD (Radiation Oncology) is a Consultant, Radiation Oncology at Apollo Cancer Centres, Navi Mumbai. He has more than 15 years of experience in Radiation Oncology and has been extensively trained at Tata Memorial Hospital.

Dr. Sandeep De has worked with leading healthcare providers of the country in his tenure of 15 years and has also been designated as the Head of the Department for one of the leading hospitals in Mumbai.

His areas of interest in Radiation Oncology include:

• Image Guided Radiation Therapy (IGRT)
• Stereotactic Body Radiation Therapy (SBRT)
• Helical Tomotherapy
• Particle Therapy
• Sterotactic Radiosurgery
• Prostrate Brachytherapy
• Neuro-Oncology
• Paediatric Radiation Oncology

Dr. Sandeep De is an avid contributor to academics and has 8 publications listed to his credit. He also has numerous research works on the various projects he has undertaken.

Dr. Sandeep De is affiliated with below mentioned societies:

• Member of Association of Radiation Oncologists of India (AROI)
• Member of Indian Association for Hyperthermia & Oncologic Medicine (IAHOM)
• Associate member of American Association for Cancer Research (AACR)
• European Society for Therapeutic Radiology and Oncology (ESTRO)

Dr. Dipalee Borade MBBS, DMRT Radiation Oncology, DNB Radiation Oncology, is Consultant at Apollo Cancer Centres, Navi Mumbai. She has a rich experience of 8 years in her field. Dr. Dipalee has work experience with advanced radiation technologies for all solid and haematological malignancies. She has expertise in the brachytherapy of gynaecological malignancies, head and neck cancer, sarcoma. She has presented papers in various national and international conferences. She is also involved in many social activities conducted by the foundations helping cancer patients.

Dr. Borade specialises in the following procedures:

• Gynaecological & Breast malignancies
• Interstitial Brachytherapy (Gynaecological, Head & Neck, Breast and Sarcoma, prostate cancer)
• Stereotactic radiosurgery (SRS), Stereotactic body radiotherapy (SBRT)
• Cancer genetics clinic

She is also a member of the following prestigious societies:

• Maharashtra Medical Council
• Association of Radiation Oncologists of India
• Indian Brachytherapy Society

Dr. Borade has been honoured with the following awards and achievements:

• Oral Paper presentation in Scientific Session at 4th FARO (Federation of Asian Organizations for Radiation Oncology) Meeting 2019, from November 14th-16th at La Waterfront Hotel, Shenzhen, China
• Poster presentation at ESTRO meets ASIA 2018 conference at Singapore
• Oral paper presentation at 12th International Conference of Asian Clinical Oncology Society (ACOS) 2016, New Delhi

She has also has the following research and publications to her credit:

• Radiation induced volume changes in Salivary glands in head and neck cancer patients receiving IMRT, March 2017, Radiotherapy and Oncology
• The effect of induction chemotherapy followed by chemoradiotherapy in advanced head and neck cancer: a prospective study, January 2014
• High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option, November 2018, Journal of Contemporary Brachytherapy
• Follow up dysphagia in head and neck cancers is related to RT dose received by swallowing structures, March 2017, Radiotherapy and Oncology
• Analysis of Newer Treatment Techniques in Clinical Outcomes of High Grade Glioma: Volumetric Arc Therapy Versus Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy, October 2017, International Journal of Radiation Oncology

Dr. Anand Zade MBBS, DNB, FEBNM, is Consultant & Head, Department of Nuclear Medicine at Apollo Hospitals Navi Mumbai. He comes with over 11 years of experience.

He is one of the most experienced Nuclear Medicine Physician in Oncological Imaging. He did DNB, (Nuclear Medicine) from prestigious Narayana Hrudayalaya Institute of Medical Sciences, Bangalore. He gained experience in PET-CT Imaging at Tata Memorial Hospital, Mumbai which is the premiere tertiary care Hospital for Cancer catering to approximate 60,000 new cancer patients annually. He was actively involved in performing Transarterial Radioembolisation therapy for primary and secondary hepatic malignancies. His main areas of interest are PET-CT & Gamma Camera Imaging, Radionuclide therapy for hepatic malignancies, neuroendocrine tumors, prostate cancers and bone pain palliation therapy.

He was appointed as Consultant & Head, Molecular Imaging at Nueclear Healthcare, Navi Mumbai since 2012. He was instrumental in commissioning of the department which is one of the busiest PET-CT Departments in the country performing approximately 25-30 PET-CT scans daily.

He has a strong academic record with several publication in peer reviewed pubmed indexed National and International journals. He has presented various original research work in National and International Conferences. In his illustrious career of 9 years he has independently reported more than 40,000 PET-CT scans. He received Fellowship of European Board of Nuclear Medicine in 2016. He received Award of Excellence in Nuclear Medicine in July 2018.

He is associated with Apollo Hospitals Navi Mumbai since July 2018. He has started services of PSMA PET-CT scans, Fluoride Bone scans and Radionuclide Bone Pain palliation for skeletal metastases.

Dr. Punit Jain, MD (Gen Medicine), DM (Clinical Haematology) is a Consultant Hematologist, Hemato-Oncologist & Program Co-ordinator Bone Marrow Transplant (BMT) at Apollo Cancer Centres, Navi Mumbai. He holds an additional fellowship in the management of leukemias from MD Anderson Cancer Center, Houston (US).

His areas of interest lie in managing all types of blood related disorders. These include several bleeding disorders like hemophilias (factor deficiencies), von willebrand disease, thrombophilia's (inherent ability to excessively clot), refractory anemias, thrombocytopenia's, aplastic anemias, myelodysplasias, myeloproliferative disorders like polycythemias, essential thrombocytosis and myelofibrosis.

Dr. Jain has special interest in treating blood malignancies like leukemias, multiple myelomas and lymphomas. In addition, his passion lies in conducting autologous and allogeneic bone marrow transplants in several diseases like thalassemia, aplastic anemias, multiple myelomas, immunodeficiency disorders and several leukemias / lymphomas.

Dr. Punit Jain has several publications, posters, abstracts at several national and international conferences to his credit.

He is also a recipient of 'ASH Abstract achievement' award on retrospective analysis on 550 adult patients with acute lymphoblastic leukemia, at the annual American society of hematology conference in 2015. The study has been recently accepted in the Journal of Global Oncology.

Dr. Punit Jain holds the membership of the following associations / societies:

• Association of Physicians of India (APICON)
• Indian Medical Association (IMA)
• Indian society of Hematology and Transfusion Medicine (ISHBT)
• Mumbai Hematology Group (MHG)

Dr. Vipin Khandelwal is a highly acclaimed clinician in the field of Paediatric Haemato-Oncology and Bone Marrow Transplant (BMT). With more than 10 years of experience, he has helped in accomplishment of more than 1000 bone marrow transplants, predominantly in paediatric patients suffering from various haematological disorders.

He worked as a consultant and incharge of Paediatric Haemato-Oncology in department of haematooncology and BMT unit at BLK-MAX Superspeciality hospital for the last 9 years. He was a part of BMT team who has performed maximum number of bone marrow transplants in North India.

Dr. Vipin completed MBBS from Dr. S N Medical College, Rajasthan in 2003, MD (Paed.) from Maulana Azad Medical College, Delhi in 2008, and DNB Fellowship in Paediatric Haemato- Oncology and BMT from Apollo Cancer Hospital, Chennai in 2013. He was also observer in Tata memorial hospital, Mumbai in department of paediatric oncology.

Dr. Vipin has a keen interest in research and has multiple publications both at National and International level to his credit.

His areas of interest include

• Bone Marrow Transplant for Thalassemia, Sickle cell disease
• Haploidentical haematopoeitic stem cell transplant
• Primary immunodeficiency disease
• Inherited marrow failure syndromes